August 21, 2024 Intelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024 August 13, 2024 Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries August 1, 2024 Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway July 24, 2024 Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia July 18, 2024 Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success July 9, 2024 Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts June 28, 2024 Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results June 27, 2024 Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions June 20, 2024 Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector June 18, 2024 Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
August 21, 2024 Intelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024
August 13, 2024 Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries
August 1, 2024 Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
July 24, 2024 Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia
July 18, 2024 Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success
July 9, 2024 Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts
June 28, 2024 Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
June 27, 2024 Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
June 20, 2024 Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector
June 18, 2024 Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
